The costs of blockbuster weight-loss drugs, projected to double again this year, will likely boost premiums for Blue Cross ...
Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.
Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...
Medici writes a recent survey from hiring platform Checkr found 58% of Americans looking for jobs said securing an interview ...
The agriculture community needs to focus on the implications of the use of weight-loss drugs and the world reaching “peak” ...
Nearly one-third of adult employees would change jobs in order to gain coverage. As the demand for GLP-1 weight loss ...
That's a potential steal. The average stock in the Health Care Select Sector SPDR Fund trades at a multiple of just under 18 ...
GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has conclu ...
Diabetes and obesity are growing health concerns worldwide. A type of medication called GLP-1 receptor agonists, commonly ...
Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...
Companies such as PepsiCo and Mondelēz haven’t seen an impact on business, while Healthy Choice maker Conagra sees the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results